The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration ; volume:12 ; number:1 ; day:18 ; month:11 ; year:2022 ; pages:1-8 ; date:12.2022
Scientific reports ; 12, Heft 1 (18.11.2022), 1-8, 12.2022
- Creator
-
Bae, Ki Woong
Kim, Dong Ik
Hwang, Daniel Duck-Jin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-23392-6
- URN
-
urn:nbn:de:101:1-2023013121182894898249
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bae, Ki Woong
- Kim, Dong Ik
- Hwang, Daniel Duck-Jin
- SpringerLink (Online service)
Other Objects (12)
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
Unexpected Vision Loss following Six Intravitreal Injections for Neovascular Age-Related Macular Degeneration
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration
Photodynamic therapy of choroidal neovascular membranes associated with exudative age-related macular degeneration
Correlations between subfoveal choroidal thickness, macular thickness, and visual outcome in neovascular age-related macular degeneration using swept source OCT: insights from intravitreal aflibercept treatment
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection for Refractory Neovascular Age-Related Macular Degeneration
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
The effect of four loading intravitreal aflibercept injections on macular fluid in treatment-naïve neovascular age-related macular degeneration
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
Unexpected Vision Loss following Six Intravitreal Injections for Neovascular Age-Related Macular Degeneration
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration
Photodynamic therapy of choroidal neovascular membranes associated with exudative age-related macular degeneration
Correlations between subfoveal choroidal thickness, macular thickness, and visual outcome in neovascular age-related macular degeneration using swept source OCT: insights from intravitreal aflibercept treatment
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection for Refractory Neovascular Age-Related Macular Degeneration
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
The effect of four loading intravitreal aflibercept injections on macular fluid in treatment-naïve neovascular age-related macular degeneration
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
Unexpected Vision Loss following Six Intravitreal Injections for Neovascular Age-Related Macular Degeneration
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration
Photodynamic therapy of choroidal neovascular membranes associated with exudative age-related macular degeneration
Correlations between subfoveal choroidal thickness, macular thickness, and visual outcome in neovascular age-related macular degeneration using swept source OCT: insights from intravitreal aflibercept treatment
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection for Refractory Neovascular Age-Related Macular Degeneration
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy